Yervoy/Opdivo (nivolumab/ipilimumab)

pCPA File Number: 20986

Negotiation Status:

Concluded with an LOI

Indication(s):

Metastatic Melanoma

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CADTH Project Number:

pCODR 10098

pCPA Engagement Letter Issued:

2018-06-13

Negotiation Process Concluded:

2019-03-20